“Researchers in Japan who have been developing a cell therapy for macular degeneration received support from health authorities to begin a clinical trial using donor-derived induced pluripotent stem (IPS) cells converted to retinal cells. This will be the first trial in which the team’s physicians administer donor cells, an approach expected to lower costs and preparation time.”
Read more at The Scientist.
Japanese Scientists Conduct Human Stem Cell Trial for Macular Degeneration